FountainRx Specialty Pharmacy earns URAC performance measurement recognition

FountainRx Specialty Pharmacy was named a 2025 Pioneer in URAC’s Leaders in Performance Measurement program, highlighting the Tennessee-based specialty pharmacy’s work tracking quality, adherence and access metrics to improve patient care. The recognition comes as FountainRx rolls out new patient and provider portals and a next-generation pharmacy management platform.

Why it matters: - URAC’s recognition highlights specialty pharmacies that use measurable quality data to improve patient care, access to treatment and operational performance. - For FountainRx, the award signals external validation of a strategy built around clinical support, patient engagement and continuous improvement. - The recognition also matters for providers and patients who rely on specialty pharmacy services for complex therapies that can be delayed by administrative or care coordination gaps.

What happened: - FountainRx Specialty Pharmacy was recognized as a 2025 Pioneer in URAC’s Leaders in Performance Measurement program. - The designation goes to select URAC-accredited organizations that advance healthcare quality through patient care measurement and improvement. - FountainRx said the recognition reflects its focus on continuous improvement across the patient journey. - The company is headquartered in Morristown, Tennessee, and serves patients nationwide.

The details: - FountainRx monitors quality measures tied to patient engagement, therapy adherence, treatment access, operational performance and clinical support. - The pharmacy uses those data-driven insights to reduce delays and improve outcomes for patients and providers. - Joseph Huntsman, chief executive officer and partner, said the team works to remove barriers to therapy, improve the patient experience and support providers with better tools and communication. - Ryan Hollingsworth, PharmD, chief operating officer and partner, said the recognition validates work happening behind the scenes and reflects a focus on getting better for patients. - Derek Hicks, PharmD, chief clinical officer and partner, said specialty pharmacy includes helping patients navigate complex therapies, supporting adherence and serving as an extension of the healthcare team. - Over the past six months, FountainRx launched FRxConnect patient and provider portals and a next-generation pharmacy management platform. - FountainRx said those investments are meant to improve the specialty pharmacy experience, while increasing service quality, efficiency and patient outcomes. - FountainRx was founded in 2012. - The pharmacy says it is quadruple-accredited through URAC and ACHC. - FountainRx serves a wide range of specialty disease states. - Keri Hunter, MBA, chief strategy officer, is listed as the media contact, along with the phone number +1 844-990-9993. - FountainRx included a LinkedIn page: FountainRx on LinkedIn.

Between the lines: - The award positions FountainRx as a pharmacy that treats measurement as an operating discipline, not just a reporting requirement. - The timing suggests FountainRx is pairing recognition with product and workflow upgrades to strengthen its case with providers, health plans and manufacturers. - The emphasis on transparency and accountability points to a broader effort to differentiate on service and measurable outcomes in a crowded specialty pharmacy market.

What's next: - FountainRx said it will continue investing in technology, clinical excellence and collaborative partnerships. - The company is likely to keep using performance data to guide service improvements and patient support. - The new portals and pharmacy management platform appear to be part of an ongoing push to deepen engagement and streamline operations.

The bottom line: - FountainRx is using URAC recognition to reinforce a message that better measurement can translate into better specialty pharmacy care.